LONA LONA
Company Profile ↓Company Overview
LONA (LONA) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +107.01% |
| 6 Months: | +65.16% |
| 3 Months: | -20.25% |
| 1 Month: | -12.13% |
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)46.85 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 34.2% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -1.53M | -1.27M | -2.25M | -7.40M | -10.78M | -16.64M | -17.83M | -23.39M | -23.57M | -24.13M | -29.77M | -31.64M | -35.04M | -27.69M | -28.03M | -29.62M | -9.54M | -7.29M | -6.87M | -17.21M |
| Net Income | -1.53M | -1.80M | -1.99M | -8.46M | -8.87M | -13.97M | -15.67M | -20.98M | -24.34M | -20.19M | -27.82M | -29.60M | -32.97M | -26.34M | -26.86M | -28.74M | -9.14M | -6.97M | -6.61M | -32.95M |
| Diluted EPS | - | - | - | - | - | - | -0.42 | -0.56 | -0.65 | -0.53 | -0.73 | -0.78 | -0.87 | -0.69 | -0.70 | -7.46 | -2.34 | -0.18 | -1.68 | -1.73 |
| R&D Expense | 1.03M | 592.00K | 1.68M | 5.83M | 7.45M | 12.02M | 10.71M | 14.46M | 14.80M | 16.96M | 21.29M | 21.61M | 27.20M | 21.24M | 22.15M | 17.92M | 4.30M | 3.66M | 2.83M | 11.26M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Operating Income | -5.45M | -20.00M | -64.02M | -104.02M | -125.47M | -100.90M | -102.27M |
| Net Income | -5.16M | -19.95M | -54.85M | -95.64M | -117.67M | -96.94M | -105.61M |
| Diluted EPS | - | - | -1.49 | -2.53 | -3.09 | -25.19 | -24.70 |
| R&D Expense | 3.79M | 13.29M | 42.79M | 61.46M | 93.79M | 70.68M | 17.50M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 2.19M | 279.56M | 332.01M | 258.15M | 160.25M | 58.78M | 92.15M |
| Total Equity | -14.89M | -19.72M | 274.28M | 321.08M | 235.14M | 130.19M | 44.84M | 27.79M |
| Cash & Equivalents | - | 2.06M | 60.62M | 110.54M | 95.97M | 90.58M | 48.44M | 69.28M |
| Total Liabilities | - | 4.86M | 5.28M | 10.92M | 23.02M | 30.06M | 13.94M | 64.36M |
| Current Liabilities | - | 1.27M | 4.41M | 9.29M | 21.43M | 28.84M | 13.13M | 47.50M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.71M | -24.11M | -43.10M | -72.47M | -100.75M | -97.17M | -45.73M |
| Investing Cash Flow | 1.51M | -210.07M | -4.08M | 57.66M | 95.09M | 54.83M | -15.89M |
| Financing Cash Flow | 946.00K | 292.75M | 97.09M | 654.00K | 493.00K | 194.00K | 82.46M |
| Capital Expenditure | - | -2.32M | -1.57M | -1.14M | -304.00K | -33.00K | - |
| Free Cash Flow | - | -26.43M | -44.67M | -73.61M | -101.06M | -97.20M | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - | - |
| ROE % | 26.2% | -7.3% | -17.1% | -40.7% | -90.4% | -216.2% | -380.0% |
| ROCE % | -594.9% | -7.3% | -19.8% | -43.9% | -95.5% | -221.1% | -229.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for LONA
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFBLRk9EdGZzQ1RwODBsWnRvTXE3Y053UmRCNHJiTm9ub2xlbVBudWpSdWhncDdXakgxZ1JQN1I3MjF4NVhlazRuSTd5RnlpMzQt?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
LeonaBio, Inc. (LONA) stock price, news, quote and history - Yahoo Finance UK
<a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTE9kT180LXhkNS1wMU05ek5UdkRMbEh0TkRVam91cGxWdEV5b2JmZWx6cl9ZVWJjWS1jYnR4WDh3Mk5xcEZLaU5xVGk2VmFQb0RoeUE?oc=5" target="_blank">LeonaBio, Inc. (LONA) stock price, news, quote and histo…
LeonaBio, Inc. Revenue Breakdown – NASDAQ:LONA - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE9UdFlyNElKbE9rbW5GUUJualV2SFJwNzJuRGFqTWZiMVprb1podDRNVjdyTmtlN2FLUU9iZ01SOHdwX2hGVDBoTklBR0hMcmJYeG5XT2VsWGpVTXA5TV84cEFqeHlVTF8tU3NuS3ZqT2JzYjM5elZJ?oc=5" target="_blank">LeonaBi…
What is the current Price Target and Forecast for LeonaBio, Inc. (LONA) - Zacks Investment Research
<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTFBmWjFZREx5OEpkMlVIeDUyLWVvWVI3dFZFaUVfU2RORmNmejZRMWJCcWI0dDVyM0RUS1o2N3JUNTVEdXdLRmdqak0wR3R6VmFPWGV1QS1MbS1nejA3NDQ5VHJMcG5yVkZQd2xfaXhUckZpVFJ1R3ZCVg?oc=5" target="_blank">What …
LeonaBio (LONA) Tumbles 8.4% as Stock Tests Key Support Levels Near $7.42 - Put Support - po-news-eg.net
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQZFdZajB1S1I0d1JQUVVBcm1rQUNVYnVJaHlQODRrV1ZJUTktMGVjOTJRUDFDNnhmQkVBbkMxclVpNmNEWGpEQ3QzN2xQc3JjbERyeFZhcG9vaGMwWUxGV1BBZFBGMEFrSjc1TDBiN1BJRWdHZklRdHk3NXpYOVMtaTZGbk1vUXZoU01OUl…
Piper Sandler initiates LeonaBio stock with overweight rating - Investing.com
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxQOWR0aHdYOTRlcE9QRTRGSTdsVXFJU21PcFlVVzZQRnhpaV9ObkRUeTFfZWxBamtXTmd3UTVXdDgtTW9aaG00ZmpyYlg1RnRQVG01YVdackM1ZHFTajRLMUx0UU9WMG5zUkVmaE1JNk5GM3FURTlZSFkxNFV2RzhmZmVOUGlWZFJNZUVBbl…
LONA — Frequently Asked Questions
What is the current share price of LONA?
As of 2026-08-05 17:25 PDT, LONA trades at $7.68 on NASDAQ/NYSE. Its 52-week range is $3.60 to $11.68.
What is the P/E ratio of LONA?
LONA trades at a trailing price-to-earnings (P/E) ratio of -0.31.
Is LONA a good stock to buy?
This page provides a data-driven analysis of LONA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.